To include your compound in the COVID-19 Resource Center, submit it here.

Amplimmune grants Daiichi option for autoimmune product AMP-110

Amplimmune Inc. (Rockville, Md.) granted Daiichi Sankyo Co. Ltd. (Tokyo:4568; Osaka:4568) an exclusive option to license worldwide rights

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE